Trial intelligence / Profile preview

Lipotoxin vs Saline for Refractory Overactive Bladder

NCT01167257Phase 2Completed

Sponsor
Buddhist Tzu Chi General Hospital
Start
May 2010
Primary completion
Dec 2013
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of botulinum toxin type A in overactive bladder syndrome (OAB), sponsored by Buddhist Tzu Chi General Hospital. Started May 2010; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

overactive bladder syndrome (OAB)

Beyond the preview

Go deeper on NCT01167257.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01167257.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call